Mizuho Securities downgraded Myriad Genetics (NASDAQ: MYGN) from Outperform to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change Downgrades

JMP Securities Upgrades Myriad Genetics (MYGN) to Market OutperformFebruary 4, 2015 7:08 AM Credit Suisse Downgrades Myriad Genetics (MYGN) to UnderperformFebruary 4, 2015 6:42 AM Myriad Genetics (MYGN) CEO to RetireFebruary 3, 2015 4:11 PM Myriad Genetics (MYGN) Tops Q2 EPS by 5c; Cuts FY15 OutlookFebruary 3, 2015 4:08 PM